Testing effectiveness (Phase 2)UnknownNCT04990557
What this trial is testing
CRISPR/Cas9-modified Human T Cell ( PD-1and ACE2 Knockout Engineered T Cells ) for Inducing Long-term Immunity in COVID-19 Patients
Who this might be right for
COVID-19 Respiratory Infection
Mahmoud Ramadan mohamed Elkazzaz 16